Home › Large Granular Lymphocytic Leukemia › Massachusetts › Boston
Large Granular Lymphocytic Leukemia clinical trials in Boston, MA
3 studies for Large Granular Lymphocytic Leukemia are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Ruxolitinib for the Treatment of T-Cell Large Granular Lymphocytic Leukemia
RecruitingPhase 2
- Dana-Farber Cancer Institute, Boston
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
RecruitingPhase 1/2
- Dren Investigational Site, Boston
A Registry for People With T-cell Lymphoma
RecruitingObservational study
- Massachusetts General Hospital (Data Collection Only), Boston
- Dana Farber Cancer Institute (Data Collection Only), Boston
Large Granular Lymphocytic Leukemia trials in other cities
Other studies in Boston
- Breast Cancer110 studies
- Cancer (all types)90 studies
- Non-Small Cell Lung Cancer87 studies
- Lung Cancer63 studies
- Colorectal Cancer62 studies
- Ovarian Cancer62 studies
- Metastatic Cancer61 studies
- Prostate Cancer56 studies
- Endometrial Cancer51 studies
- Depression50 studies
- Heart Failure46 studies
- Multiple Myeloma45 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.